Frankfurt Stock Exchange · Regulated Market, General Standard · LEOW
A holding company building a global integrated AI-driven healthcare ecosystem.
With a strategic focus on AI-driven precision health assets across Healthcare Services, MedTech, HealthTech and Biotech, LIPH offers investors access to the expanding Asian and global healthcare and life sciences market.
- 6
- Majority shareholdings
- EUR 198.8m
- Total assets
- 87%
- Equity ratio
- LEOW
- Frankfurt General Standard
Contributed December 2025
As of December 31, 2025
Equity of EUR 172.9 million
ISIN DE0005490601
The company
Where expertise meets dedication
Leo International Precision Health AG (“LIPH”, ticker symbol: LEOW) is a holding company building a global integrated AI-driven healthcare ecosystem. With a strategic focus on AI-driven precision health assets across Healthcare Services, MedTech, HealthTech and Biotech, LIPH offers investors access to the expanding Asian and global healthcare and life sciences market. By reconfiguring assets, LIPH integrates technology, data, and operations to accelerate medical outcomes and portfolio performance.
As LIPH AG continues to connect technology, care, and capital, it aims to deliver sustainable value creation for shareholders while shaping the future of intelligent, data-driven healthcare globally.
Focus areas
- Healthcare Services
- MedTech
- HealthTech
- Biotech
Share information
- Ticker
- LEOW
- ISIN
- DE0005490601
- WKN
- 549060
- Exchange
- Frankfurt Stock Exchange
- Segment
- Regulated Market, General Standard
- Shares issued
- 106,560,000
Portfolio
Six majority shareholdings
amiko AI
54% shareholding
An artificial intelligence technology company focused on applications in drug discovery and precision medicine.
Taipei, Taiwan · Founded 2019
Danner Laboratory Inc.
51% shareholding
A CLIA-certified diagnostic laboratory founded in 1991 specializing in cytological and molecular diagnostics with a focus on oncology.
San Diego, CA / USA · Founded 1984
Dr PAIN
100% shareholding
A provider of non-surgical pain therapy and rehabilitation services with operations in Taiwan, Hong Kong and China.
Hong Kong · Founded 2018
UHO Wellness Corporation
67% shareholding
A company that develops complementary healthcare solutions in the field of supportive care for cancer patients.
Taipei City, Taiwan · Founded 2018
Pathomics Health Pte Ltd.
52% shareholding
A precision medicine and molecular diagnostics company founded in 2017 and headquartered in Singapore, with a regional focus on Southeast Asia.
Singapore · Founded 2018
Renhe Biotech (Australia) Pty. Ltd.
51% shareholding
A company founded in 2020, and headquartered in Australia, operating in the dietary supplements segment with a focus on “healthy aging.”
Victoria, Australia · Founded 2020
Newsroom
Latest news releases
Press release
Leo International Precision Health AG Announces Results of the 2026 Annual General Meeting
Press release
Leo International Precision Health AG builds a Synchronised, End-to-End Precision Healthcare Engine Across the Entire Patient Journey
Inside information
Leo International Precision Health AG approves cash capital increase excluding subscription rights
Contact
Enquiries from investors, partners and media
Investor relations: ir@liphag.com